# BROADWOOD CAPITAL INC: Form 13F holdings

An institutional investment manager in New York, NY. SEC CIK 1278387.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $1.91bn
- Positions: 6 (6 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1278387/000091957426005163/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [MONSTER BEVERAGE CORP NEW (MNST)](/companies/mnst.md) | COM | $779.3m | 40.7% | 8,107,796 |  | Unchanged |
| [STAAR SURGICAL CO (STAA)](/companies/staa.md) | COM PAR $0.01 | $462.6m | 24.2% | 16,123,842 |  | Unchanged |
| [AXON ENTERPRISE INC (AXON)](/companies/axon.md) | COM | $388.8m | 20.3% | 693,504 |  | Unchanged |
| ISHARES TR | RUSSELL 2000 ETF | $142.7m | 7.5% | 474,920 |  | Unchanged |
| [INSIGHT MOLECULAR DIA INC (IMDX)](/companies/imdx.md) | COM NEW | $74.8m | 3.9% | 12,684,884 |  | Added +753,045 |
| [LINEAGE CELL THERAPEUTICS IN (LCTX)](/companies/lctx.md) | COM | $64.9m | 3.4% | 49,560,992 |  | Unchanged |

Source: SEC EDGAR, Form 13F-HR, accession 0000919574-26-005163. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.